| How Are Clinical
Studies of Mental Disorders Designed?
Clinical researchers call the standard scientific approach for
trying out treatments a double-blind, randomized, controlled clinical
trial. Understanding this term, and knowing how and why this approach
is used, should help you to decide whether to become a research
volunteer.
An important part of scientific research is comparison. Clinical
research often will compare an investigational treatment to one
that is used frequently and thus has familiar, or predictable, effects.
To make the comparison useful, the investigator must try both methods
on similar groups of subjects.
Researchers call the treatment with the predictable or known effect
the control. The control may be a standard, commonly used treatment,
or it may be a placebo. A placebo is something that does not directly
affect the illness or symptoms under study in any specific way.
(You may have heard a placebo described as a "sugar pill.")
Some studies use both a standard treatment and a placebo as controls.
The control helps an investigator find out if any changes seen
in patients in the experimental group are, in fact, due to the new
treatment.
The term randomized means how a researcher assigns each patient
to a particular treatment under study. Researchers assign patients
by chance either to a group taking the new treatment (called the
treatment group) or to a group taking a standard treatment or a
placebo (called the control group). This method, called randomization,
helps avoid bias: having the study's results affected by human choices
or other factors not related to the treatments being tested. In
some studies, researchers do not tell the patient whether he or
she is in the treatment or control group (called a single-blind
study). This approach is another way to avoid bias, because when
people know what drug they are taking, it might change the way they
react. For instance, patients who knew they were taking the new
treatment might expect it to work better and report hopeful signs
because they want to believe they are getting well. This could bias
the study by making the results look better than they really were.
Random assignment helps to make sure that those in the group who
receive an investigational treatment are similar to those in the
group who receive the control treatment. By making certain that
all who take part are similar, random assignment helps a researcher
to make better conclusions.
The term double-blind in research design means that neither you
nor the researcher will know if you are assigned to the experimental
or to the control group. The aim is to avoid letting either the
investigator's hopes or expectations about a particular treatment
or your hopes and expectations influence the manner in which he
or she views improvements and side effects.
Your random assignment to a particular treatment group usually
will occur after the researcher decides that you can be in the study,
and after you agree to join the research by signing an informed
consent form.
back
|